|
⚲
|
| Keyboard |
| Walter Olesiak | |
|---|---|
| Firm | |
| Address | c/o Launchlabs 430 E 29th St, 14th Floor New York, NY 10016 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| ENB Therapeutics Inc | 021-493707 | Director | 0.2 M of 1.0 M |
||
| Napajen Pharma Inc | 021-413786 | Executive Officer | 0.5 M of 2.0 M |
||
| Axikin Pharmaceuticals Inc | 021-175874 | Director | 2.0 M of 11.0 M |
||
| Axikin Pharmaceuticals Inc | 021-146289 | Director | 1.0 M of 7.0 M |
||
| Remiges Ventures Inc | |||||
| Remiges Biopharma Fund II LP | 021-342260 | Director | of 150.0 M |
95.0 M | |
| Remiges Biopharma Fund LP | 021-218532 | Executive Officer | 80.0 M of 80.0 M |
80.0 M | |